Cerenis raises €40m for development of “good cholesterol” therapeutics | AltAssets Private Equity News

Subscribe today

Advanced
Search

Cerenis raises €40m for development of “good cholesterol” therapeutics

26 Jul 2010

Cerenis Therapeutics, a French biopharmaceutical company that develops "good cholesterol" to treat cardiovascular ailments, has raised €40m in Series C financing and appointed the former CEO of pharmaceuticals giant GlaxoSmithKline to its board.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.